These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 32523732)

  • 1. Strontium-substituted sub-micron bioactive glasses inhibit ostoclastogenesis through suppression of RANKL-induced signaling pathway.
    Huang D; Zhao F; Gao W; Chen X; Guo Z; Zhang W
    Regen Biomater; 2020 Jun; 7(3):303-311. PubMed ID: 32523732
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Synergistic effect of strontium and silicon in strontium-substituted sub-micron bioactive glass for enhanced osteogenesis.
    Zhang W; Huang D; Zhao F; Gao W; Sun L; Li X; Chen X
    Mater Sci Eng C Mater Biol Appl; 2018 Aug; 89():245-255. PubMed ID: 29752095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strontium-Substituted Submicrometer Bioactive Glasses Modulate Macrophage Responses for Improved Bone Regeneration.
    Zhang W; Zhao F; Huang D; Fu X; Li X; Chen X
    ACS Appl Mater Interfaces; 2016 Nov; 8(45):30747-30758. PubMed ID: 27779382
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The synergistic effects of Sr and Si bioactive ions on osteogenesis, osteoclastogenesis and angiogenesis for osteoporotic bone regeneration.
    Mao L; Xia L; Chang J; Liu J; Jiang L; Wu C; Fang B
    Acta Biomater; 2017 Oct; 61():217-232. PubMed ID: 28807800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 12-O-tetradecanoylphorbol-13-acetate (TPA) inhibits osteoclastogenesis by suppressing RANKL-induced NF-kappaB activation.
    Wang C; Steer JH; Joyce DA; Yip KH; Zheng MH; Xu J
    J Bone Miner Res; 2003 Dec; 18(12):2159-68. PubMed ID: 14672351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strontium inhibits titanium particle-induced osteoclast activation and chronic inflammation via suppression of NF-κB pathway.
    Zhu S; Hu X; Tao Y; Ping Z; Wang L; Shi J; Wu X; Zhang W; Yang H; Nie Z; Xu Y; Wang Z; Geng D
    Sci Rep; 2016 Oct; 6():36251. PubMed ID: 27796351
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of RANKL-induced osteoclastogenesis by (-)-DHMEQ, a novel NF-kappaB inhibitor, through downregulation of NFATc1.
    Takatsuna H; Asagiri M; Kubota T; Oka K; Osada T; Sugiyama C; Saito H; Aoki K; Ohya K; Takayanagi H; Umezawa K
    J Bone Miner Res; 2005 Apr; 20(4):653-62. PubMed ID: 15765185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced ectopic bone formation by strontium-substituted calcium phosphate ceramics through regulation of osteoclastogenesis and osteoblastogenesis.
    Chen F; Tian L; Pu X; Zeng Q; Xiao Y; Chen X; Zhang X
    Biomater Sci; 2022 Oct; 10(20):5925-5937. PubMed ID: 36043373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maslinic acid suppresses osteoclastogenesis and prevents ovariectomy-induced bone loss by regulating RANKL-mediated NF-κB and MAPK signaling pathways.
    Li C; Yang Z; Li Z; Ma Y; Zhang L; Zheng C; Qiu W; Wu X; Wang X; Li H; Tang J; Qian M; Li D; Wang P; Luo J; Liu M
    J Bone Miner Res; 2011 Mar; 26(3):644-56. PubMed ID: 20814972
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dual actions of osteoclastic-inhibition and osteogenic-stimulation through strontium-releasing bioactive nanoscale cement imply biomaterial-enabled osteoporosis therapy.
    Lee NH; Kang MS; Kim TH; Yoon DS; Mandakhbayar N; Jo SB; Kim HS; Knowles JC; Lee JH; Kim HW
    Biomaterials; 2021 Sep; 276():121025. PubMed ID: 34298444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 18β-Glycyrrhetinic Acid Inhibits Osteoclastogenesis
    Chen X; Zhi X; Yin Z; Li X; Qin L; Qiu Z; Su J
    Front Pharmacol; 2018; 9():647. PubMed ID: 29973878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Garcinol suppresses RANKL-induced osteoclastogenesis and its underlying mechanism.
    Jia Y; Jiang J; Lu X; Zhang T; Zhao K; Han W; Yang W; Qian Y
    J Cell Physiol; 2019 May; 234(5):7498-7509. PubMed ID: 30471112
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The cross-talk between osteoclasts and osteoblasts in response to strontium treatment: involvement of osteoprotegerin.
    Peng S; Liu XS; Huang S; Li Z; Pan H; Zhen W; Luk KD; Guo XE; Lu WW
    Bone; 2011 Dec; 49(6):1290-8. PubMed ID: 21925296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis.
    Bharti AC; Takada Y; Aggarwal BB
    J Immunol; 2004 May; 172(10):5940-7. PubMed ID: 15128775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stattic inhibits RANKL-mediated osteoclastogenesis by suppressing activation of STAT3 and NF-κB pathways.
    Li CH; Xu LL; Jian LL; Yu RH; Zhao JX; Sun L; Du GH; Liu XY
    Int Immunopharmacol; 2018 May; 58():136-144. PubMed ID: 29587202
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulation of osteogenesis and osteoclastogenesis by zoledronic acid loaded on biodegradable magnesium-strontium alloy.
    Li M; Wan P; Wang W; Yang K; Zhang Y; Han Y
    Sci Rep; 2019 Jan; 9(1):933. PubMed ID: 30700724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strontium-substituted bioactive glasses in vitro osteogenic and antibacterial effects.
    Liu J; Rawlinson SC; Hill RG; Fortune F
    Dent Mater; 2016 Mar; 32(3):412-22. PubMed ID: 26777094
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin 29 inhibits RANKL-induced osteoclastogenesis via activation of JNK and STAT, and inhibition of NF-κB and NFATc1.
    Peng Q; Luo A; Zhou Z; Xuan W; Qiu M; Wu Q; Xu L; Kong X; Zhang M; Tan W; Xue M; Wang F
    Cytokine; 2019 Jan; 113():144-154. PubMed ID: 30001863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Icariin inhibits RANKL-induced osteoclastogenesis via modulation of the NF-κB and MAPK signaling pathways.
    Xu Q; Chen G; Liu X; Dai M; Zhang B
    Biochem Biophys Res Commun; 2019 Jan; 508(3):902-906. PubMed ID: 30538045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.